Results
2301
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2301 companies
Orthocell
Market Cap: AU$296.4m
A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.
OCC
AU$1.23
7D
-0.4%
1Y
226.7%
CARGO Therapeutics
Market Cap: US$190.4m
A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.
CRGX
US$4.22
7D
2.9%
1Y
-77.4%
scPharmaceuticals
Market Cap: US$189.0m
A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.
SCPH
US$3.55
7D
1.3%
1Y
-11.5%
Eledon Pharmaceuticals
Market Cap: US$188.6m
Operates as a clinical stage biotechnology company.
ELDN
US$3.09
7D
2.3%
1Y
19.8%
Kodiak Sciences
Market Cap: US$188.4m
A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
KOD
US$3.50
7D
-1.0%
1Y
18.6%
Pacific Smiles Group
Market Cap: AU$291.7m
Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.
PSQ
AU$1.81
7D
1.4%
1Y
-4.7%
Inhibrx Biosciences
Market Cap: US$186.9m
A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.
INBX
US$13.75
7D
9.6%
1Y
-13.3%
Kindly MD
Market Cap: US$186.7m
A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.
NAKA
US$24.23
7D
6.1%
1Y
n/a
Sight Sciences
Market Cap: US$186.6m
An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.
SGHT
US$3.52
7D
7.3%
1Y
-46.0%
Omeros
Market Cap: US$185.7m
A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.
OMER
US$3.14
7D
1.0%
1Y
-4.8%
Avacta Group
Market Cap: UK£136.5m
Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.
AVCT
UK£0.38
7D
32.7%
1Y
-12.8%
High Tide
Market Cap: CA$254.1m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.09
7D
-2.5%
1Y
-3.4%
Panamera Holdings
Market Cap: US$182.0m
Does not have significant operations.
PHCI
US$4.49
7D
12.3%
1Y
349.0%
Journey Medical
Market Cap: US$181.8m
Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$8.07
7D
18.3%
1Y
112.4%
Organigram Global
Market Cap: CA$250.4m
Engages in the production and sale of cannabis and cannabis-derived products in Canada.
OGI
CA$1.87
7D
-1.1%
1Y
-20.4%
UroGen Pharma
Market Cap: US$181.2m
Engages in the development and commercialization of solutions for urothelial and specialty cancers.
URGN
US$4.05
7D
-2.9%
1Y
-69.5%
Deltex Medical Group
Market Cap: US$180.6m
Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.
DTXM.F
US$0.095
7D
0%
1Y
n/a
Stereotaxis
Market Cap: US$180.6m
Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
STXS
US$2.12
7D
5.0%
1Y
5.5%
TriSalus Life Sciences
Market Cap: US$180.4m
Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.
TLSI
US$5.57
7D
2.4%
1Y
-25.7%
ProQR Therapeutics
Market Cap: US$179.1m
A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.
PRQR
US$1.74
7D
3.0%
1Y
-4.9%
DiaMedica Therapeutics
Market Cap: US$178.4m
A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.
DMAC
US$4.19
7D
3.5%
1Y
51.3%
Spectral Medical
Market Cap: CA$245.2m
Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.
EDT
CA$0.85
7D
2.4%
1Y
80.9%
CVRx
Market Cap: US$176.0m
A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.
CVRX
US$6.80
7D
2.3%
1Y
-1.2%
AFT Pharmaceuticals
Market Cap: NZ$294.7m
Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.
AFT
NZ$2.81
7D
4.1%
1Y
-7.0%
Inogen
Market Cap: US$175.6m
A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
INGN
US$6.53
7D
-3.3%
1Y
-19.5%
Utah Medical Products
Market Cap: US$175.6m
Provides medical devices for the healthcare industry worldwide.
UTMD
US$54.58
7D
1.7%
1Y
-18.7%
Instil Bio
Market Cap: US$175.5m
A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.
TIL
US$30.35
7D
23.3%
1Y
174.9%
INmune Bio
Market Cap: US$170.8m
A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.
INMB
US$7.36
7D
-1.9%
1Y
-22.8%
Electromed
Market Cap: US$170.5m
Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.
ELMD
US$20.41
7D
0.3%
1Y
38.0%
Cybin
Market Cap: US$170.4m
A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.
CYBN
US$8.06
7D
11.0%
1Y
-39.3%
Puma Biotechnology
Market Cap: US$167.3m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$3.38
7D
4.0%
1Y
-11.3%
AC Immune
Market Cap: US$167.2m
A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.
ACIU
US$1.68
7D
1.8%
1Y
-54.2%
Lucid Diagnostics
Market Cap: US$164.4m
Operates as a commercial-stage medical diagnostics technology company in the United States.
LUCD
US$1.52
7D
14.3%
1Y
67.6%
AVITA Medical
Market Cap: US$164.2m
Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.
RCEL
US$5.77
7D
-9.8%
1Y
-38.0%
Accuray
Market Cap: US$163.8m
Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.
ARAY
US$1.58
7D
0%
1Y
0.6%
Procaps Group
Market Cap: US$163.6m
Develops, produces, and markets pharmaceutical solutions worldwide.
PROC.F
US$0.01
7D
-99.3%
1Y
-99.6%